The Series B extension brings Atavistik Bio’s Series B financing to $160 million. The startup’s lead program is in development for hereditary hemorrhagic telangiectasia (HHT), an inherited bleeding disorder. The post Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies appeared first on MedCity News.
Sonali Saluja, M.D., M.P.H., vice president of population health and medical director of Healthcare in Action, describes importance of data availability to mobile care teams
For healthcare leaders, actionable SDOH insights are key to advancing equity and improving patient outcomes. By investing in comprehensive engagement strategies and leveraging technology, the healthcare industry can build trust, address barriers to care, and ensure that no patient falls through the cracks. The post Putting SDOH Data to Work for Systems and Patients appeared…
We are on the cusp of being held accountable not just for what we did wrong, but for what we failed to do, especially when readily available, life-saving technology could have made a difference. The post When Inaction Becomes Negligence in the Age of AI appeared first on MedCity News.
When Pam McClure learned she’d save nearly $4,000 on her prescription drugs next year, she said, “it sounded too good to be true.” She and her husband are both retired and live on a “very strict” budget in central North Dakota. By the end of this year, she will have spent almost $6,000 for her…
This is the moment to build flexible plans. Organizations that develop operational models with built-in scenario planning, ready to scale up or down as the capital environment shifts, will be positioned to take advantage of greater investment when it comes. The post Weathering the Shifting Trial Landscape appeared first on MedCity News.
Thomas Deringer, PhD, Vice President, Experience, shares his thoughts on improving perceptions of clean within healthcare settings. Cleanliness in healthcare isn’t just about appearance—it’s a critical factor in patient safety and trust. In the wake of COVID-19, patients are more attuned to cleanliness in healthcare settings, and have higher expectations and standards for what constitutes…
People with disabilities have long fought for the right to live at home rather than in institutions. Now, the Department of Justice says states don’t have to help make that happen. The decision by the Trump administration comes amid massive cuts in federal funding for Medicaid. Advocates worry this could be a one-two punch for…
This brief provides an update on Planned Parenthood closures and participation in the Title X program in the midst of substantial policy changes leading to decreased funding for Planned Parenthood including the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.
MeiraGTx’s gene therapy for Parkinson’s disease will enter Phase 3 testing under a new joint venture the biotech is forming with Hologen, a generative AI startup. The joint venture has up to $230 million in committed capital; MeiraGTx gets additional cash for its pipeline. The post Gene Therapy Biotech MeiraGTx Strikes Deal Bringing Generative AI…